Summary Sequenom, Inc. (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby's whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetricians as well as patients. Its MDCLs are located at San Diego, California; Raleigh-Durham, North Carolina; and Grand Rapids, Michigan. Sequenom is headquartered in San Diego, California, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Sequenom, Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Sequenom, Inc. Company Snapshot 6 Sequenom, Inc. Company Overview 6 Sequenom, Inc. Pipeline Products and Clinical Trials Overview 7 Sequenom, Inc. - Pipeline Analysis Overview 9 Business Description 9 Key Facts 9 Sequenom, Inc. - Major Products and Services 10 Sequenom, Inc. Pipeline Products by Development Stage 11 Sequenom, Inc. Pipeline Products Overview 13 ctDNA Based Laboratory Developed Test 13 ctDNA Based Laboratory Developed Test Product Overview 13 MassARRAY System Enhancements 14 MassARRAY System Enhancements Product Overview 14 Next Generation Noninvasive Prenatal Test (NIPT) 15 Next Generation Noninvasive Prenatal Test (NIPT) Product Overview 15 Preanalytical Solution-Fetal DNA Analysis 16 Preanalytical Solution-Fetal DNA Analysis Product Overview 16 SensiGene Age Related Macular Degeneration Assay 17 SensiGene Age Related Macular Degeneration Assay Product Overview 17 VisibiliT Prenatal Test 18 VisibiliT Prenatal Test Product Overview 18 Sequenom, Inc. - Key Competitors 19 Sequenom, Inc. - Key Employees 20 Sequenom, Inc. - Key Employee Biographies 21 Sequenom, Inc. - Locations And Subsidiaries 22 Head Office 22 Other Locations & Subsidiaries 22 Recent Developments 24 Sequenom, Inc., Recent Developments 24 Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent 24 May 04, 2016: Sequenom Reports First Quarter 2016 Results 24 May 03, 2016: Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin 26 Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations 26 Apr 12, 2016: Sequenom Strengthens Executive Team with New Vice President of Sales 26 Mar 21, 2016: Sequenom Files Petition With the Supreme Court of the United States Requesting Review Of Decision On '540 Patent 27 Mar 02, 2016: Sequenom Announces Contract with Anthem BlueCross 27 Mar 02, 2016: Sequenom Reports 2015 Financial Results 27 Feb 25, 2016: Sequenom Laboratories Announces Positive Results from Clinical Validation Study on the MaterniT GENOME Test 29 Jan 11, 2016: Sequenom Announces Preliminary 2015 Results 30 Appendix 31 Methodology 31 About GlobalData 31 Contact Us 31 Disclaimer 31
List of Tables
Sequenom, Inc. Pipeline Products and Clinical Trials Overview 7 Sequenom, Inc. Pipeline Products by Equipment Type 7 Sequenom, Inc. Pipeline Products by Indication 8 Sequenom, Inc., Key Facts 9 Sequenom, Inc., Major Products and Services 10 Sequenom, Inc. Number of Pipeline Products by Development Stage 11 Sequenom, Inc. Pipeline Products Summary by Development Stage 12 ctDNA Based Laboratory Developed Test - Product Status 13 ctDNA Based Laboratory Developed Test - Product Description 13 MassARRAY System Enhancements - Product Status 14 MassARRAY System Enhancements - Product Description 14 Next Generation Noninvasive Prenatal Test (NIPT) - Product Status 15 Next Generation Noninvasive Prenatal Test (NIPT) - Product Description 15 Preanalytical Solution-Fetal DNA Analysis - Product Status 16 Preanalytical Solution-Fetal DNA Analysis - Product Description 16 SensiGene Age Related Macular Degeneration Assay - Product Status 17 SensiGene Age Related Macular Degeneration Assay - Product Description 17 VisibiliT Prenatal Test - Product Status 18 VisibiliT Prenatal Test - Product Description 18 Sequenom, Inc., Key Employees 20 Sequenom, Inc., Key Employee Biographies 21 Sequenom, Inc., Other Locations 22 Sequenom, Inc., Subsidiaries 22
List of Figures
Sequenom, Inc. Pipeline Products by Equipment Type 8 Sequenom, Inc. Pipeline Products by Development Stage 11
Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. IncreasinRead More...
Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance drivRead More...
Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from mainRead More...
Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demandRead More...
Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global demRead More...
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.